Dr. Matthew C. Abramowitz, MD
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Temple University School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 391
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Temple University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
FL license ME101659
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University of Miami (2,377 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 391
- Services billed
- 2,539
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Ct guidance for insertion of radiation therapy fields | 1,237 | 118 |
| Calculation of radiation therapy dose | 266 | 57 |
| Radiation treatment management, 5 treatment sessions | 258 | 73 |
| Established patient office or other outpatient visit, 20-29 minutes | 241 | 178 |
| New patient office or other outpatient visit, 60-74 minutes | 65 | 65 |
| Established patient office or other outpatient visit, 30-39 minutes | 64 | 58 |
| High precision radiation therapy planning | 55 | 53 |
| Design and construction of radiation treatment device for high precision radiation therapy | 42 | 42 |
| Design and construction of complex radiation treatment device | 39 | 20 |
| Complex radiation therapy planning | 21 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Miami, FL | 139 |
| Ciprofloxacin Hcl Other prescribers in Miami, FL | 25 |
| Ibuprofen Other prescribers in Miami, FL | 18 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Miami, FL | 13 |
| Sildenafil Citrate Other prescribers in Miami, FL | 12 |
| Bicalutamide | 11 |
| Gabapentin Other prescribers in Miami, FL | 11 |
| Methylprednisolone Other prescribers in Miami, FL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 14 payments worth $9,448 in total to this clinician.
| Siemens Medical Solutions USA, Inc. | $8,915 |
|---|---|
| Novartis Pharmaceuticals Corporation | $336 |
| Boston Scientific Corporation | $169 |
| Servier Pharmaceuticals LLC | $28.38 |
| Consulting Fee | $7,200 |
|---|---|
| Travel and Lodging | $1,752 |
| Food and Beverage | $496 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Siemens Medical Solutions USA, Inc. Mar 11, 2025 | Consulting Fee TrueBeam · Oncology | $3,600 |
| Siemens Medical Solutions USA, Inc. Jul 23, 2025 | Consulting Fee TrueBeam · Oncology | $3,600 |
| Siemens Medical Solutions USA, Inc. Jul 23, 2025 | Travel and Lodging TrueBeam · Oncology · travel to Las Vegas, NV | $788 |
| Siemens Medical Solutions USA, Inc. Mar 11, 2025 | Travel and Lodging TrueBeam · Oncology · travel to Las Vegas, NV | $619 |
| Siemens Medical Solutions USA, Inc. Mar 11, 2025 | Travel and Lodging TrueBeam · Oncology · travel to Las Vegas, NV | $181 |
| Siemens Medical Solutions USA, Inc. Jul 23, 2025 | Travel and Lodging TrueBeam · Oncology · travel to Las Vegas, NV | $126 |
| Novartis Pharmaceuticals Corporation Mar 1, 2025 | Travel and Lodging travel to Miami, FL | $37.45 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $279 in research payments for these studies, mostly to the institutions running them.
- An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.